HEALTH CATALYST INC.

Health Catalyst completed the sale of its Vitalware business unit to Med-Metrix on July 31 and received a total of $147 million in cash (before adjustments). Using the proceeds and existing cash, the company fully repaid its credit facility, eliminating approximately $19 million in annual interest expense on a GAAP basis. Health Catalyst will now focus on core products for cost control, improving clinical quality and customer retention, as well as on intelligence products. » Plus sur de.investing.com

Med-Metrix, backed by Harvest Partners and A&M Capital Partners, has signed a definitive agreement to acquire Vitalware from Health Catalyst. Vitalware provides cloud-based software for chargemaster management, revenue integrity, price transparency and coding workflows; financial terms were not disclosed. The deal remains subject to customary closing conditions, and Vitalware’s leadership team and employees are expected to join Med-Metrix. The acquisition expands Med-Metrix’s technology platform for revenue cycle management, particularly in the mid-revenue cycle. » Plus sur de.investing.com

Health Catalyst has agreed to sell Vitalware to Med‑Metrix for $147 million in cash. The company intends to use the net proceeds to fully repay its first‑lien secured loan facility and improve its capital structure. Vitalware generated approximately $37 million in revenue in fiscal 2025; the transaction is expected to close in 2026. After the sale, Health Catalyst will focus on its core technology and investments in artificial intelligence. » Plus sur de.investing.com